Most potential oncology drugs fail during the drug development pipeline, even when there has been promising data for their efficacy during the in vitro stage. This makes it vital to identify in ...

Integrated protocols and live-cell analysis solutions for different 3D tumor models In the search for greater clinical translation, cancer researchers are increasingly turning to more complex ...

A research group has developed a technology for mass-producing uniform artificial cells (lipid bilayer vesicles) with artificial model nuclei using microfluidic devices with high reproducibility.

Using a newly devised, three-dimensional model to study the regeneration of nerve tissue in the nose, researchers at School ...

With an increasing push to improve safety, efficacy, and efficiency throughout the drug development pipeline, researchers are evermore looking to improve the predictive capacity of their in vitro ...

Next the scientists developed 3D models using the cells and infected them with Candida albicans, a yeast that can cause serious infections in people with weak immune systems or cleft lips.

This next-generation platform empowers scientists to create complex, reproducible 3D cell models with minimal hands-on time, making advanced biology more accessible. Empowering Researchers with ...

In a world-first, Swiss scientists have developed 3D cell models using lip cells, an advance that can help develop new treatments for injuries and infections. To date, models using lip cells ...

The majority of potential oncology drugs fail at some stage of the drug development pipeline, despite demonstrating promising in vitro efficacy data. This common phenomenon is driving the ...